FOXO4-DRI
10mg
- Purity ≥99%, verified by HPLC and mass spectrometry
- 10 mg FOXO4-DRI per vial
- Lyophilized powder (peptide)
€199.99€288.99Preorder
Buy more, save moreAuto-applied
1
Preorder: ships as soon as it is back in stock.
- Free gifts from €200: sample, bacteriostatic water, full-size product
- Secure checkout · Tracked, discreet EU dispatch
FOXO4-DRI€199.99
Testing and Certificate of Analysis
Every batch is tested by an independent laboratory using HPLC and mass spectrometry before release. The Certificate of Analysis for your batch is sent on request.
- Test number
- FOXO4-2501-A
- Method
- HPLC + ESI-MS
- Purity target
- ≥99%
Specifications
| Form | Lyophilized powder (peptide) |
|---|---|
| Content | 10 mg FOXO4-DRI per vial |
| Packaging | Glass vial with sterile closure |
| Storage | 2–8 °C (refrigerated), protect from light |
| Molecular Formula | Sequence-defined D-retro-inverso peptide |
| Molecular Weight | ~4379 g·mol⁻¹ (approximate) |
| Test Number | FOXO4-2501-A |
| IUPAC Name | FOXO4-derived D-Retro-Inverso peptide (senolytic research compound) |
Independently HPLC & mass-spec verified to ≥99% purity, with a Certificate of Analysis available for every batch. Supplied as a lyophilised powder in a sealed vial. Synthesised in a controlled cleanroom, sealed and dispatched discreetly and tracked across the EU, consistent, fully documented material you can rely on, batch after batch.
For laboratory research use only. Not for human or veterinary use.
